PDL BioPharma Inc (PDLI):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:PDL BioPharma Inc (PDLI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7182
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to late-stage public and private healthcare companies. PDL provides companies, academic institutions, and inventors with an immediate financial monetization of royalty streams for acquiring new income generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. PDL is headquartered in Incline Village, Nevada, the US.

PDL BioPharma Inc (PDLI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PDL BioPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PDL BioPharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
PDL BioPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PDL BioPharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
PDL BioPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PDL BioPharma Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
LENSAR Acquires Laser Business Unit of Precision Eye Services 10
PDL BioPharma Acquires Portion of Zalviso Royalty Rights from AcelRx Pharma for USD65 Million 11
Venture Financing 13
Lensar (LaserSoft Vision) Secures USD16 Million in Venture Funding 13
Direct Flow Medical Raises US$50 Million In Venture Financing 14
LensAR Raises USD8 Million in Venture Financing 15
Kaleo To Raise US$150 Million In Venture Financing 16
LensAR Raises US$10 Million In Venture Financing 17
LensAR Raises US$17.4 Million In Venture Financing 18
LensAR Raises US$5 Million In Venture Financing 19
LensAR Raises US$24 Million In Series F Financing Round 20
Private Equity 21
LensAR Completes US$27 Million In Private Equity Financing 21
PDL BioPharma Enters into Royalty Agreement with Viscogliosi Brothers 22
Equity Offering 23
AxoGen Completes Second Tranche Of Private Placement For US$19 Million 23
Debt Offering 25
PDL BioPharma Completes Public Offering of 2.75% Convertible Senior Notes due 2021 for USD150 Million 25
Acquisition 26
Alphaeon Acquires LENSAR for USD59 Million 26
PDL BioPharma Inc – Key Competitors 27
PDL BioPharma Inc – Key Employees 28
PDL BioPharma Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
PDL BioPharma Inc, Medical Equipment, Key Facts, 2017 2
PDL BioPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
PDL BioPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PDL BioPharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
PDL BioPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PDL BioPharma Inc, Deals By Market, 2012 to YTD 2018 8
PDL BioPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
LENSAR Acquires Laser Business Unit of Precision Eye Services 10
PDL BioPharma Acquires Portion of Zalviso Royalty Rights from AcelRx Pharma for USD65 Million 11
Lensar (LaserSoft Vision) Secures USD16 Million in Venture Funding 13
Direct Flow Medical Raises US$50 Million In Venture Financing 14
LensAR Raises USD8 Million in Venture Financing 15
Kaleo To Raise US$150 Million In Venture Financing 16
LensAR Raises US$10 Million In Venture Financing 17
LensAR Raises US$17.4 Million In Venture Financing 18
LensAR Raises US$5 Million In Venture Financing 19
LensAR Raises US$24 Million In Series F Financing Round 20
LensAR Completes US$27 Million In Private Equity Financing 21
PDL BioPharma Enters into Royalty Agreement with Viscogliosi Brothers 22
AxoGen Completes Second Tranche Of Private Placement For US$19 Million 23
PDL BioPharma Completes Public Offering of 2.75% Convertible Senior Notes due 2021 for USD150 Million 25
Alphaeon Acquires LENSAR for USD59 Million 26
PDL BioPharma Inc, Key Competitors 27
PDL BioPharma Inc, Key Employees 28
PDL BioPharma Inc, Subsidiaries 29

List of Figures
PDL BioPharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
PDL BioPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
PDL BioPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
PDL BioPharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
PDL BioPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PDL BioPharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
PDL BioPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PDL BioPharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[PDL BioPharma Inc (PDLI):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OCON Medical Ltd:企業の製品パイプライン分析2018
    Summary OCON Medical Ltd (OCON Medical) is a manufacturer of women’s health products. The company provides leverages intrauterine technology to develop contraceptive intrauterine devices for women. It develops IUB SCu300, an advanced intrauterine device that is compatible with the uterine cavity. OC …
  • WD-40 Company (WDFC):企業の財務・戦略的SWOT分析
    Summary WD-40 Company (WD-40) is a lubricant distributor. The company develops and markets maintenance products, and homecare and cleaning products. Its products are used in rust and corrosion resistive, penetrates stuck parts, and moisture barriers. WD-40 also provides surface cleaners and automati …
  • Teijin Ltd (3401)-医療機器分野:企業M&A・提携分析
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • Magellan Health, Inc.:企業の戦略・SWOT・財務分析
    Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alder Biopharmaceuticals Inc (ALDR):企業の財務・戦略的SWOT分析
    Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Amica Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Amica Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Amica Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gazprom Marketing & Trading Ltd:企業の戦略的SWOT分析
    Gazprom Marketing & Trading Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Bachmann electronic GmbH:企業の戦略的SWOT分析
    Bachmann electronic GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Total Gabon SA (EC):企業の財務・戦略的SWOT分析
    Summary Total Gabon SA (Total Gabon), formerly Elf Gabon SA, a subsidiary of Total SA, is an oil and gas company that provides oil exploration and development services. The company explores and extracts hydrocarbon resources. It provides activities such as mining and exploration, production, redevel …
  • Tomophase Corp:製品パイプライン分析
    Summary Tomophase Corp (Tomophase) is a medical device company that offers light-based imaging and therapy solutions. The company develops and commercializes opto-medical devices. It offers endoscopic tissue imaging system based on its proprietary technology optical coherence tomography. Tomophase's …
  • National Jewish Health-製薬・医療分野:企業M&A・提携分析
    Summary National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a healthcare center that offers treatment of pulmonary, cardiac, immune and related disorders. The center offers services in the areas of allergy, asthma, cardiology, clinical immunology, COPD, environmenta …
  • Kura Oncology Inc (KURA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • Pampa Energia S.A (PAMP)-エネルギー分野:企業M&A・提携分析
    Summary Pampa Energia S.A. (Pampa) is an integrated energy company. It generates, transmits and distributes electricity. The company produces electricity from thermal, hydro and wind sources. Pampa explores for and produces hydrocarbon products in Argentina, Ecuador and Venezuela; refines diesel, fu …
  • ARMZ Uranium Holding Co:企業の戦略的SWOT分析
    ARMZ Uranium Holding Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Bajaj Auto Ltd:企業の戦略・SWOT・財務情報
    Bajaj Auto Ltd - Strategy, SWOT and Corporate Finance Report Summary Bajaj Auto Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cellectricon AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectricon AB (Cellectricon) is an advanced cell-based discovery service provider. The company offers automated cell-based screening technologies for drug discovery and basic research. It provides Cellaxess, a platform that allows the researchers to address critical bottlenecks in the drug …
  • DiamondRock Hospitality Co:企業のM&A・事業提携・投資動向
    DiamondRock Hospitality Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DiamondRock Hospitality Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Sony Mobile Communications AB.:企業の戦略的SWOT分析
    Sony Mobile Communications AB. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Zhejiang Jihua Group Co Ltd (603980):企業の戦略的SWOT分析
    Zhejiang Jihua Group Co Ltd (603980) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Grupa Azoty Zaklady Chemiczne Police SA (PCE):企業の財務・戦略的SWOT分析
    Grupa Azoty Zaklady Chemiczne Police SA (PCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆